These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11814362)

  • 1. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
    J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carbohydrate moiety of factor V modulates inactivation by activated protein C.
    Fernández JA; Hackeng TM; Kojima K; Griffin JH
    Blood; 1997 Jun; 89(12):4348-54. PubMed ID: 9192757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
    Ayombil F; Petrillo T; Kim H; Camire RM
    J Biol Chem; 2022 Nov; 298(11):102558. PubMed ID: 36183835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
    Gould WR; Silveira JR; Tracy PB
    J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites.
    Gale AJ; Heeb MJ; Griffin JH
    Blood; 2000 Jul; 96(2):585-93. PubMed ID: 10887122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1996 Jun; 87(11):4708-17. PubMed ID: 8639840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.
    Matsumoto T; Nogami K; Shima M
    J Thromb Haemost; 2014 Sep; 12(9):1503-12. PubMed ID: 25041532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
    Erdogan E; Bukys MA; Orfeo T; Mann KG; Kalafatis M
    Thromb Haemost; 2007 Nov; 98(5):998-1006. PubMed ID: 18000604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
    Cramer TJ; Griffin JH; Gale AJ
    Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
    J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretable human platelet-derived factor V originates from the plasma pool.
    Camire RM; Pollak ES; Kaushansky K; Tracy PB
    Blood; 1998 Nov; 92(9):3035-41. PubMed ID: 9787136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.
    Nicolaes GA; Sørensen KW; Friedrich U; Tans G; Rosing J; Autin L; Dahlbäck B; Villoutreix BO
    Eur J Biochem; 2004 Jul; 271(13):2724-36. PubMed ID: 15206937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.